Sophia Randolph
CIK 1817127 · CHIEF MEDICAL OFFICER · last filed 2024-08-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$514.6K
Companies
1
Total Filings
23
Lifetime Open-Market Net
-$4.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALXO | CHIEF MEDICAL OFFICER | 325,711 | $1.58 | $514.6K | -$4.64M | 23 | 2024-08-16 |
Recent Filings · Page 2 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-09 | ALXO | Grant (A) | +37,000 | $0 | EDGAR |
| 2021-12-16 | ALXO | Exer (M) | +23,852 | $33.8K | EDGAR |
| 2021-11-23 | ALXO | Mixed | +15,116 | -$424.9K | EDGAR |
| 2021-10-12 | ALXO | Sell (S) | −7,387 | -$450.4K | EDGAR |
| 2021-09-13 | ALXO | Sell (S) | −7,387 | -$573.7K | EDGAR |
| 2021-08-11 | ALXO | Sell (S) | −7,387 | -$477.4K | EDGAR |
| 2021-08-03 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2021-07-14 | ALXO | Sell (S) | −7,387 | -$405.5K | EDGAR |
| 2021-06-14 | ALXO | Sell (S) | −7,387 | -$449.7K | EDGAR |
| 2021-05-11 | ALXO | Sell (S) | −7,387 | -$457.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.